EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study

Bazezew Yenew iD, Abebaw Kebede, Ayinalem Alemu, Getu Diriba iD, Zemedu Mehammed, Misikir Amare, Biniyam Dagne, Waganeh Sinshaw, Ephrem Tesfaye, Dereje Beyene, Woldaregay Erku Abegaz

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0303460 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Bazezew Yenew und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Pulmonary, Antitubercular Agents, Genotype. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Ethiopian Public Health Institute, Amhara Public Health Institute, and Addis Ababa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of drug-resistant tuberculosis (DR-TB) has been a major obstacle to global tuberculosis control programs, especially in developing countries, including Ethiopia. This study investigated drug resistance patterns and associated mutations of Mycobacterium tuberculosis Complex (MTBC) isolates from the Amhara, Gambella, and Benishangul-Gumuz regions of Ethiopia.

Methods

A cross-sectional study was conducted using 128 MTBC isolates obtained from patients with presumptive tuberculosis (TB). Phenotypic (BACTEC MGIT 960) and genotypic (MTBDR plus and MTBDR sl assays) methods were used for drug susceptibility testing. Data were entered into Epi-info and analyzed using SPSS version 25. Frequencies and proportions were determined to describe drug resistance levels and associated mutations.

Results

Of the 127 isolates recovered, 100 (78.7%) were susceptible to four first-line anti-TB drugs. Any drug resistance, polydrug resistance, and multi-drug resistance (MDR) were detected in 21.3% (27), 15.7% (20), and 15% (19) of the isolates, respectively, by phenotypic and/or genotypic methods. Mono-resistance was observed for Isoniazid (INH) (2, 1.6%) and Streptomycin (STR) (2, 1.6%). There were two genotypically discordant RIF-resistant cases and one INH-resistant case. One case of pre-extensively drug-resistant TB (pre-XDR-TB) and one case of extensively drug-resistant TB (XDR-TB) were identified. The most frequent gene mutations associated with INH and rifampicin (RIF) resistance were observed in the katG MUT1 (S315T1) (20, 76.9%) and rpoB (S531L) (10, 52.6%) genes, respectively. Two MDR-TB isolates were resistant to second-line drugs; one had a mutation in the gyrA MUT1 gene, and the other had missing gyrA WT1 , gyrA WT3 , and rrs WT1 genes without any mutation.

Conclusions

The detection of a significant proportion of DR-TB cases in this study suggests that DR-TB is a major public health problem in Ethiopia. Thus, we recommend the early detection and treatment of DR-TB and universal full first-line drug-susceptibility testing in routine system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, PulmonaryAntitubercular AgentsGenotypeTuberculosis, Multidrug-ResistantMicrobial Sensitivity TestsHumansEthiopiaMaleFemaleAdultCross-Sectional StudiesMiddle AgedPhenotypeMutationYoung AdultAdolescentDrug Resistance, Multiple, BacterialIsoniazidRifampinBacterial Proteins

Substanzen

Antitubercular AgentsIsoniazidRifampinBacterial Proteins

Autor:innen und Institutionen

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

ORCID-Profile: Bazezew Yenew, Getu Diriba

Förderung

  • FIC NIH HHS
  • Ethiopian Public Health Institute, Amhara Public Health Institute, and Addis Ababa University

Zitieren

APA

Yenew, B., Kebede, A., Alemu, A., Diriba, G., Mehammed, Z., Amare, M., Dagne, B., Sinshaw, W., Tesfaye, E., Beyene, D., & Abegaz, W. E. (2024). Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study. PLOS ONE. https://doi.org/10.1371/journal.pone.0303460

Vancouver

Yenew B, Kebede A, Alemu A, Diriba G, Mehammed Z, Amare M, et al. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study. PLOS ONE. 2024. doi:10.1371/journal.pone.0303460

BibTeX
@article{Yenew2024,
  author = {Yenew, Bazezew and Kebede, Abebaw and Alemu, Ayinalem and Diriba, Getu and Mehammed, Zemedu and Amare, Misikir and Dagne, Biniyam and Sinshaw, Waganeh and Tesfaye, Ephrem and Beyene, Dereje and Abegaz, Woldaregay Erku},
  title = {Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0303460}
}
Kostenlos starten →